Prior to attending law school, Sammy worked as a clinical researcher at a leading US teaching hospital in Boston, where she investigated the role of pharmaceutical drugs on vascular health in various conditions, including HIV, breast cancer, prostate cancer, diabetes mellitus, Marfan syndrome and peripheral artery disease. She co-authored articles that appeared in the Journal of the American Heart Association and Vascular Medicine.

While in law school, Sammy was executive articles editor for the Texas Intellectual Property Law Journal. As an undergraduate at Dartmouth College, she investigated various microorganisms’ resistance to polysorbate 80 and co-authored an article that appeared in Antimicrobial Agents and Chemotherapy.

Show Less

• Represented a pharmaceutical company in the District of New Jersey in a matter related to a pain treatment*
• Represented a DNA sequencing company in the District of Delaware in a matter related to nanopore sequencing technology, resulting in a jury verdict of noninfringement and invalidity on one asserted patent and invalidity on three asserted patents*
• Represented Fujifilm before the ITC in a matter related to magnetic tape data storage technologies*
• Represented a DNA sequencing company before the ITC in a matter relating to nanopore sequencing technology, resulting in an MSD of noninfringement*
• Represented a DNA sequencing company before the ITC in a matter relating to nanopore sequencing technologies, resulting in a favorable settlement for the company*

*Matter handled prior to joining McDermott.

Show Less